Liver abnormalities in rheumatic diseases

scientific article

Liver abnormalities in rheumatic diseases is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S1089-3261(02)00052-1
P8608Fatcat IDrelease_tm7pl6bvajcszcwojho34lauhm
P698PubMed publication ID12516200

P2093author name stringRobert B Zurier
Nancy J Walker
P2860cites workStill's disease in the adultQ24514809
Sulfasalazine-induced fulminant hepatic failureQ28327415
Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritisQ33552131
Pyrophosphate arthropathy: a study of metabolic associations and laboratory dataQ33553747
Hepatic function in ankylosing spondylitisQ33554742
Increased serum alkaline phosphatase activity in ankylosing spondylitisQ33554759
Liver disease in twins with Felty's syndromeQ33566214
Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction?Q33580118
Relation between infection and autoimmunity in mixed cryoglobulinemiaQ33824793
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupQ33885648
Gastrointestinal manifestations of sclerodermaQ34487889
Inflammation-mediated rheumatic diseases and atherosclerosisQ35549285
Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patientsQ35549891
Nonsteroidal anti-inflammatory drugs and peptic ulcer diseaseQ37624998
Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodulesQ37928516
The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs.Q38509741
Epidemiology of Systemic Sclerosis (Scleroderma)Q39335161
Effect of an intravenously administered bile acid (chenodeoxycholic acid) on rheumatoid arthritisQ39590067
Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significanceQ39632711
Hepatotoxicity following the therapeutic use of antipyretic analgesicsQ40165243
Assessment of hepatic function with xenobioticsQ40377454
Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.Q40385238
Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugsQ40567553
Hepatic toxicity of antirheumatic drugsQ40804142
Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritisQ40886002
Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and preventionQ41156662
Proceedings: Liver function tests and liver biopsies in patients with rheumatoid arthritisQ41328522
Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsQ41921005
Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyQ41921017
Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samplesQ42203139
Combined hepatotoxicity and neurotoxicity following sulphasalazine administrationQ42241538
Serum alkaline phosphatase in ankylosing spondylitisQ42706417
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patientsQ44593960
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.Q45746740
Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alphaQ45758150
Hepatic safety of two analgesics used over the counter: Ibuprofen and aspirinQ52566030
Haematology and biochemistry of ankylosing spondylitis.Q53822206
Therapeutic Effect of Induced Jaundice in Rheumatoid ArthritisQ55118476
THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODYQ59032616
HLA DQα and DQβ restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritisQ62733787
Risk factors for coronary artery disease in patients with systemic lupus erythematosusQ67586359
Ulcer complications and nonsteroidal anti-inflammatory drugsQ68281422
Renal insufficiency associated with nonsteroidal anti-inflammatory agentsQ70606793
Primary biliary cirrhosisQ71742524
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndromeQ71781429
Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of RheumatologyQ72296676
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factorsQ72747718
Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiologyQ72760666
Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC aloneQ77483123
Rheumatologic manifestations of gastrointestinal diseasesQ77803126
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritisQ77993297
P433issue4
P304page(s)933-946
P577publication date2002-11-01
P1433published inClinics in liver diseaseQ26842322
P1476titleLiver abnormalities in rheumatic diseases
P478volume6

Reverse relations

cites work (P2860)
Q41837394A case of primary biliary cirrhosis in a patient with rheumatoid arthritis
Q46691712Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage.
Q24814590Idiopathic portal hypertension complicating systemic sclerosis: a case report
Q33412732Life-threatening complications of adult-onset Still's disease
Q37670283Liver involvement in patients with systemic autoimmune diseases
Q26770595Occult HCV Infection: The Current State of Knowledge
Q37951386Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review
Q46685913Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study
Q84600226[Systemic sclerosis and the gastrointestinal tract. Diagnostic and therapeutic approach]

Search more.